Ketamine is a synthetic pharmaceutical compound classified as a dissociative anesthetic and is one of the most widely used drugs in modern medicine. It is included in the World Health Organization’s List of Essential Medicines and has been FDA-approved since 1970 for anesthetic use. Due to its rapid onset and proven safety profile, ketamine has been adopted in many hospitals and medical offices. It is classified as a Schedule III drug and is legal at both state and federal levels.
Over the last two decades, off-label ketamine treatment has been increasingly utilized for chronic and treatment-resistant mental health conditions, such as depression, PTSD, anxiety disorders, substance dependencies, and alcoholism. While ongoing clinical trials are demonstrating promising results, ketamine therapy is still considered an experimental treatment for mental health disorders, as it is not FDA-approved for conditions such as depression or anxiety.
While ketamine therapy is generally well-tolerated, some individuals may experience temporary side effects, including:
These symptoms typically resolve within a few hours post-treatment. However, patients must follow pre-treatment and post-treatment protocols to minimize risks.
Ketamine therapy is not recommended for individuals with the following conditions:
Individuals with severe personality disorders or a family history of psychosis should consult with an Isha Health clinician before proceeding with ketamine therapy.
While ketamine is not typically physically addictive, it has been associated with moderate psychological dependency in recreational users. However, when administered in a controlled medical setting, the risk is significantly reduced.
In rare cases, long-term or frequent use of ketamine has been associated with urinary complications, including:
Ketamine infusion therapy has been linked to temporary cognitive impairment, dizziness, and increased blood pressure. Patients receiving ketamine infusions should have continuous medical supervision to monitor any adverse reactions.
To ensure safety and optimize treatment outcomes, patients must follow these pre-treatment guidelines:
At Isha Health, patient safety is our top priority. Our protocols include:
The primary risks include temporary cognitive impairment, dissociation, nausea, dizziness, increased blood pressure, and bladder-related issues with prolonged use. When administered in a controlled medical setting, risks are significantly reduced.
Patients undergo thorough medical evaluations, and during treatment, licensed professionals track their response to ensure safety. Virtual follow-ups and in-person evaluations help manage side effects.
Most side effects are temporary and mild, such as dizziness, increased heart rate, nausea, and mild dissociation. Following ketamine therapy safety guidelines helps mitigate these effects.
Patients should avoid alcohol, heavy meals, and stimulants, ensure they have a trusted monitor during treatment, and follow pre-treatment guidelines for the safest experience.
Individuals with severe heart conditions, uncontrolled high blood pressure, active psychosis, or pregnancy should avoid ketamine therapy. Consulting a medical professional is crucial before beginning treatment.
Ketamine therapy offers promising relief for individuals struggling with treatment-resistant depression, PTSD, and anxiety disorders. By following strict safety protocols, patients can maximize therapeutic benefits while minimizing risks. If you're considering ketamine therapy, schedule a consultation with Isha Health to ensure it's the right option for you.